Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Roberta DI BLASI"'
Autor:
Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Pierre Sesques, Guillaume Manson, Guillaume Cartron, David Beauvais, Louise Roulin, François Xavier Gros, Marie Thérèse Rubio, Pierre Bories, Jacques Olivier Bay, Cristina Castilla Llorente, Sylvain Choquet, René-Olivier Casasnovas, Mohamad Mohty, Stéphanie Guidez, Magalie Joris, Michaël Loschi, Sylvain Carras, Julie Abraham, Adrien Chauchet, Laurianne Drieu La Rochelle, Bénédicte Deau-Fischer, Olivier Hermine, Thomas Gastinne, Jean Jacques Tudesq, Elodie Gat, Florence Broussais, Catherine Thieblemont, Roch Houot, Franck Morschhauser
Publikováno v:
Nature Medicine
Nature Medicine, 2022, 28, pp.2145-2154. ⟨10.1038/s41591-022-01969-y⟩
Nature Medicine, 2022, 28, pp.2145-2154. ⟨10.1038/s41591-022-01969-y⟩
Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) have both demonstrated impressive clinical activity in relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL). In this study, we analyzed the outcome of 809 patients with R/R
Autor:
Jaap A. van Doesum, Jon Salmanton-García, Francesco Marchesi, Roberta Di Blasi, Iker Falces-Romero, Alba Cabirta, francesca farina, caroline besson, Barbora Weinbergerová, Jens Van Praet, Martin Schönlein, Alberto Lopez-Garcia, Sylvain Lamure, Anna Guidetti, Cristina De Ramón-Sánchez, Josip Batinic, Eleni Gavriilaki, Athanasios Tragiannidis, Maria Chiara Tisi, Gaëtan Plantefeve, Verena Petzer, Irati Ormazabal-Velez, Joyce Marques de Almeida, Monia Marchetti, Johan A. Maertens, Marina Machado, Austin G Kulasekararaj, José Ángel Hernández-Rivas, Maria Gomes da Silva, Noemí Fernández, Ildefonso Espigado, Lubos Drgona, Giulia Dragonetti, Elisabetta Metafuni, Maria Calbacho, Ola Blennow, Dominik Wolf, Bjorn van Anrooij, Raquel Nunes Rodrigues, Anna Nordlander, Juan-Alberto MARTÍN-GONZÁLEZ, Raphaël Lievin, Moraima Jiménez, Stefanie K Grafe, Ramon Garcia-Sanz, Raúl Córdoba, Laman Rahimli, Tom van Meerten, Oliver A Cornely, Livio Pagano
Publikováno v:
Blood Advances.
Patients with previous CD19 directed chimeric antigen receptor T cell therapy (CAR T)-cell therapy have a prolonged vulnerability to viral infections. Coronavirus diseases 2019 (COVID-19) has a great impact and has previously been shown to cause high
Autor:
Federico Erbella, Emmanuel Bachy, Guillaume Cartron, Elodie Gat, Franck Morschhauser, Benoit Tessoulin, Olivier Tournilhac, Choquet Sylvain, François-Xavier Gros, Cristina Castilla-Llorente, Arnaud Campidelli, René-Olivier Casasnovas, Louise Roulin, Pierre Bories, Mohamad Mohty, Martin Carre, Steven Le Gouill, Roch Houot, Roberta Di Blasi
Publikováno v:
Blood. 140:1325-1327
Autor:
Johan Maertens, Austin Kulesekararaj, Carolina Garcia-Vidal, Nina Khanna, Ildefonso Espigado, Alessandro Busca, Martin Hoenigl, Philipp Koehler, Anna Guidetti, Nikolai Klimko, Ramón García-Sanz, Josip Batinić, Alba Cabirta, Antonio Pagliuca, Rémy Duléry, Francesca Farina, Oliver A. Cornely, Jon Salmanton-García, Sylvain Lamure, Anna Nordlander, Francesco Passamonti, Lubos Drgona, Francesco Marchesi, Barbora Weinbergerova, Alberto Lopez-Garcia, Iker Falces-Romero, Livio Pagano, Paolo Corradini, Roberta Di Blasi
Publikováno v:
Scientia
Blood advances, vol 6, iss 7
Blood Advances
Blood advances, vol 6, iss 7
Blood Advances
Patients receiving chimeric antigen receptor T cells (CAR-T cells) therapy may be particularly susceptible to coronavirus disease 2019 (COVID-19) because of several factors including the immunosuppression associated to the underlying disease and dela
Autor:
Roberta Di Blasi, Steven Le Gouill, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Fabien Le Bras, François-Xavier Gros, Sylvain Choquet, Pierre Bories, Pierre Feugier, Olivier Casasnovas, Jacques Olivier Bay, Mohamad Mohty, Magalie Joris, Thomas Gastinne, Pierre Sesques, Jean-Jacques Tudesq, Laetitia Vercellino, Franck Morschhauser, Elodie Gat, Florence Broussais, Roch Houot, Catherine Thieblemont
Publikováno v:
Blood
Blood, 2022, 140 (24), pp.2584-2593. ⟨10.1182/blood.2022016945⟩
Blood, 2022, 140 (24), pp.2584-2593. ⟨10.1182/blood.2022016945⟩
Anti-CD19 chimeric antigen receptor (CAR) T-cells represent a major advance in the treatment of relapsed/refractory aggressive B-cell lymphomas. However, a significant number of patients experience failure. Among 550 patients registered in the French
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f52e802b137cf7c6a7b3707c88d4c12
https://univ-rennes.hal.science/hal-03903472/document
https://univ-rennes.hal.science/hal-03903472/document
Autor:
Roberta Di Blasi, Laure Philippe, Thomas Hueso, Catherine Thieblemont, Karine Lacombe, Bénédicte Deau Fischer, Serge Bologna, Caroline Besson, Guillemette Fouquet, Sylvain Choquet, Milena Kohn, Rémy Duléry, Carole Soussain, Bernard Drenou, Pierre Feugier, Etienne Daguindau, Marc Delord, Nicolas Noel, Adrien Chauchet, Sylvain Lamure, Sandra Malak, Cédric Rossi, Bertrand Joly, Guillaume Cartron, Yassine Taoufik
Publikováno v:
American Journal of Hematology
American Journal of Hematology, Wiley, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
American Journal of Hematology, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
American Journal of Hematology, Wiley, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
American Journal of Hematology, 2021, 96 (8), pp.934-944. ⟨10.1002/ajh.26209⟩
International audience; Prolonged Covid-19 is an emerging issue for patients with lymphoma or immune deficiency. We aimed to examine prolonged length of in-hospital stay (LOS) due to Covid-19 among patients with lymphoma and assess its determinants a
Autor:
Adrian Bloor, Nicolaus Kröger, Gloria Tridello, Alvaro Urbano-Ispizua, Roberta Di Blasi, Joaquin Martinez-Lopez, František Folber, Josep-Maria Ribera, Elisabetta Metafuni, Robin Sanderson, Marie José Kersten, Catherine Thieblemont, Friso Calkoen, Livia Giannoni, Pim G.N.J. Mutsaers, Matthew Collin, Arnon Nagler, Emma Nicholson, Emmanuel Bachy, Fiona L Dignan, Valentín Ortiz-Maldonado, Dolores Caballero, Johan Maertens, Per Ljungman, Pere Barba, Carlos Pinho Vaz, Francis Ayuk, Mi Kwon, Fabio Ciceri, Stephan Mielke, Pierre Sesques, Nina Knelange, Anne M. Spanjaart, Rafael de la Cámara
Publikováno v:
Scientia
Leukemia, 35(12), 3585-3588. Nature Publishing Group
Leukemia
Leukemia, 35(12), 3585-3588. Nature Publishing Group
Leukemia
Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Càncer hematològic; Malalties infeccioses Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Cáncer hematológico; Enfermedades infecciosas Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Haematological cancer;
Autor:
Ola Blennow, Jon Salmanton‐García, Piotr Nowak, Federico Itri, Jaap Van Doesum, Alberto López‐García, Francesca Farina, Ozren Jaksic, László Imre Pinczés, Yavuz M. Bilgin, Iker Falces‐Romero, Moraima Jiménez, Irati Ormazabal‐Vélez, Barbora Weinbergerová, Rémy Duléry, Zlate Stojanoski, Tobias Lahmer, Noemí Fernández, José‐Ángel Hernández‐Rivas, Verena Petzer, Nick De Jonge, Andreas Glenthøj, Cristina De Ramón, Monika M. Biernat, Nicola Fracchiolla, Avinash Aujayeb, Jens Van Praet, Martin Schönlein, Gustavo‐Adolfo Méndez, Chiara Cattaneo, Anna Guidetti, Mariarita Sciumè, Emanuele Ammatuna, Raul Cordoba, Nicole García‐Poutón, Stefanie Gräfe, Alba Cabirta, Dominik Wolf, Anna Nordlander, Ramón García‐Sanz, Mario Delia, Caroline Berg Venemyr, Clara Brones, Roberta Di Blasi, Elizabeth De Kort, Stef Meers, Sylvain Lamure, Laura Serrano, Maria Merelli, Nicola Coppola, Rui Bergantim, Caroline Besson, Milena Kohn, Jessica Petiti, Carolina Garcia‐Vidal, Michelina Dargenio, François Danion, Marina Machado, Rebeca Bailén‐Almorox, Martin Hoenigl, Giulia Dragonetti, Louis Yi Ann Chai, Chi Shan Kho, Matteo Bonanni, Raphaël Liévin, Francesco Marchesi, Oliver A. Cornely, Livio Pagano
Publikováno v:
Scientia
Blennow, O, Salmanton-García, J, Nowak, P, Itri, F, Van Doesum, J, López-García, A, Farina, F, Jaksic, O, Pinczés, L I, Bilgin, Y M, Falces-Romero, I, Jiménez, M, Ormazabal-Vélez, I, Weinbergerová, B, Duléry, R, Stojanoski, Z, Lahmer, T, Fernández, N, Hernández-Rivas, J Á, Petzer, V, De Jonge, N, Glenthøj, A, De Ramón, C, Biernat, M M, Fracchiolla, N, Aujayeb, A, Van Praet, J, Schönlein, M, Méndez, G A, Cattaneo, C, Guidetti, A, Sciumè, M, Ammatuna, E, Cordoba, R, García-Poutón, N, Gräfe, S, Cabirta, A, Wolf, D, Nordlander, A, García-Sanz, R, Delia, M, Berg Venemyr, C, Brones, C, Di Blasi, R, De Kort, E, Meers, S, Lamure, S, Serrano, L, Merelli, M, Coppola, N, Bergantim, R, Besson, C, Kohn, M, Petiti, J, Garcia-Vidal, C, Dargenio, M, Danion, F, Machado, M, Bailén-Almorox, R, Hoenigl, M, Dragonetti, G, Chai, L Y A, Kho, C S, Bonanni, M, Liévin, R, Marchesi, F, Cornely, O A & Pagano, L 2022, ' Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies : An EPICOVIDEHA survey report ', American Journal of Hematology, vol. 97, no. 8, pp. E312-E317 . https://doi.org/10.1002/ajh.26626
Blennow, O, Salmanton-García, J, Nowak, P, Itri, F, van Doesum, J, López-García, A, Farina, F, Jaksic, O, Pinczés, L S I, Bilgin, Y M, Falces-Romero, I, Jiménez, M, Ormazabal-Vélez, I, Weinbergerová, B, Duléry, R M, Stojanoski, Z, Lahmer, T, Fernández, N, Hernández-Rivas, J-Á, Petzer, V, de Jonge, N, Glenthøj, A, de Ramón, C, Biernat, M M, Fracchiolla, N, Aujayeb, A, van Praet, J, Schönlein, M, Méndez, G-A, Cattaneo, C, Guidetti, A, Sciumè, M, Ammatuna, E, Cordoba, R, García-Poutón, N, Gräfe, S, Cabirta, A, Wolf, D, Nordlander, A, García-Sanz, R, Delia, M, Berg Venemyr, C, Brones, C, di Blasi, R, de Kort, E, Meers, S, Lamure, S, Serrano, L, Merelli, M, Coppola, N, Bergantim, R, Besson, C, Kohn, M, Petiti, J, Garcia-Vidal, C, Dargenio, M, Danion, F, Machado, M, Bailén-Almorox, R, Hoenigl, M, Dragonetti, G, Chai, L Y A, Kho, C S, Bonanni, M, Liévin, R, Marchesi, F, Cornely, O A & Pagano, L 2022, ' Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies : An EPICOVIDEHA survey report ', American Journal of Hematology, vol. 97, no. 8, pp. E312-E317 . https://doi.org/10.1002/ajh.26626
American Journal of Hematology, 97, E312-e317
AMERICAN JOURNAL OF HEMATOLOGY
American Journal of Hematology, 97(8), E312-E317. Wiley
American Journal of Hematology, 97, 8, pp. E312-e317
American Journal of Hematology, 97(8), E312-E317. Wiley-Liss Inc.
Blennow, O, Salmanton-García, J, Nowak, P, Itri, F, Van Doesum, J, López-García, A, Farina, F, Jaksic, O, Pinczés, L I, Bilgin, Y M, Falces-Romero, I, Jiménez, M, Ormazabal-Vélez, I, Weinbergerová, B, Duléry, R, Stojanoski, Z, Lahmer, T, Fernández, N, Hernández-Rivas, J Á, Petzer, V, De Jonge, N, Glenthøj, A, De Ramón, C, Biernat, M M, Fracchiolla, N, Aujayeb, A, Van Praet, J, Schönlein, M, Méndez, G A, Cattaneo, C, Guidetti, A, Sciumè, M, Ammatuna, E, Cordoba, R, García-Poutón, N, Gräfe, S, Cabirta, A, Wolf, D, Nordlander, A, García-Sanz, R, Delia, M, Berg Venemyr, C, Brones, C, Di Blasi, R, De Kort, E, Meers, S, Lamure, S, Serrano, L, Merelli, M, Coppola, N, Bergantim, R, Besson, C, Kohn, M, Petiti, J, Garcia-Vidal, C, Dargenio, M, Danion, F, Machado, M, Bailén-Almorox, R, Hoenigl, M, Dragonetti, G, Chai, L Y A, Kho, C S, Bonanni, M, Liévin, R, Marchesi, F, Cornely, O A & Pagano, L 2022, ' Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies : An EPICOVIDEHA survey report ', American Journal of Hematology, vol. 97, no. 8, pp. E312-E317 . https://doi.org/10.1002/ajh.26626
Blennow, O, Salmanton-García, J, Nowak, P, Itri, F, van Doesum, J, López-García, A, Farina, F, Jaksic, O, Pinczés, L S I, Bilgin, Y M, Falces-Romero, I, Jiménez, M, Ormazabal-Vélez, I, Weinbergerová, B, Duléry, R M, Stojanoski, Z, Lahmer, T, Fernández, N, Hernández-Rivas, J-Á, Petzer, V, de Jonge, N, Glenthøj, A, de Ramón, C, Biernat, M M, Fracchiolla, N, Aujayeb, A, van Praet, J, Schönlein, M, Méndez, G-A, Cattaneo, C, Guidetti, A, Sciumè, M, Ammatuna, E, Cordoba, R, García-Poutón, N, Gräfe, S, Cabirta, A, Wolf, D, Nordlander, A, García-Sanz, R, Delia, M, Berg Venemyr, C, Brones, C, di Blasi, R, de Kort, E, Meers, S, Lamure, S, Serrano, L, Merelli, M, Coppola, N, Bergantim, R, Besson, C, Kohn, M, Petiti, J, Garcia-Vidal, C, Dargenio, M, Danion, F, Machado, M, Bailén-Almorox, R, Hoenigl, M, Dragonetti, G, Chai, L Y A, Kho, C S, Bonanni, M, Liévin, R, Marchesi, F, Cornely, O A & Pagano, L 2022, ' Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies : An EPICOVIDEHA survey report ', American Journal of Hematology, vol. 97, no. 8, pp. E312-E317 . https://doi.org/10.1002/ajh.26626
American Journal of Hematology, 97, E312-e317
AMERICAN JOURNAL OF HEMATOLOGY
American Journal of Hematology, 97(8), E312-E317. Wiley
American Journal of Hematology, 97, 8, pp. E312-e317
American Journal of Hematology, 97(8), E312-E317. Wiley-Liss Inc.
SARS-CoV-2; Hematological malignancies SARS-CoV-2; Neoplasias hematológicas SARS-CoV-2; Neoplasies hematològiques Optics COMMIT (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30b2c426d6f36954db06c33625cdf06
https://hdl.handle.net/11351/9362
https://hdl.handle.net/11351/9362
Autor:
Sandrine Valade, Michael Darmon, Lara Zafrani, Eric Mariotte, Virginie Lemiale, Swann Bredin, Guillaume Dumas, Nicolas Boissel, Florence Rabian, André Baruchel, Isabelle Madelaine, Jérôme Larghero, Anne Brignier, Etienne Lengliné, Stéphanie Harel, Bertrand Arnulf, Roberta Di Blasi, Catherine Thieblemont, Elie Azoulay
Publikováno v:
Annals of intensive care. 12(1)
Background CAR-T cell (chimeric antigen receptor T) therapy has emerged as an effective treatment of refractory hematological malignancies. Intensive care management is intrinsic to CAR-T cell therapy. We aim to describe and to assess outcomes in cri
Autor:
Inès Boussen, Quentin Lisan, Emmanuel Raffoux, Roberta Di Blasi, Nicolas Boissel, Eric Oksenhendler, Lionel Adès, Aliénor Xhaard, Stéphane Bretagne, Alexandre Alanio, Jean-Michel Molina, Blandine Denis
Publikováno v:
Open Forum Infectious Diseases. 9
Background Hepatosplenic candidiasis (HSC) used to be reported in patients with acute myeloid leukemia (AML) without antifungal prophylaxis. The aim was to describe the clinical features and outcomes of HSC over the last 13 years in a single French h